FDA shows green light to Zontivity, blood-clot drug that lowers stroke, heart attack risks The U.S. FDA approved Zontivity, a new drug to reduce the risk of stroke, heart attack and death from cardiovascular diseases. Zontivity increases the risk of bleeding and the FDA issues a recommendation on how to safely use it. by Anne Francis